Search Results 1061-1070 of 16736 for intermittent fasting optimization
To establish a repository of DNA samples collected prospectively from patients with inherited myopathies of unknown molecular and/or biochemical defect. To ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
About this study. The purpose of this study is to learn more about the cause of the different patterns and colors seen in melanomas, with the hope of better ...
ddp-gaining-control-6col · Print. Sections. Products and services. The Mayo Clinic Diet: What is your weight-loss goal? 5-10. Mayo Clinic neurosurgeon Kendall H ...
The purpose of this study is to assess the feasibility of using the current FDA-approved AliveCor Kardia device and their AliveCor Tripod device (FDA ...
... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...
Ian Parney, M.D., Ph.D., Neurosurgery, Mayo Clinic: In some cases, this is something to manage the metastatic brain tumor burden for patients but isn't ...
The purpose of this study is to test the use of patient managed ECG monitoring devices and individually tailored medication plans to allow patients with ...
To identify demographic, clinical and radiologic factors associated with long terms outcomes of NMOSD; To determine if patients who are diagnosed with the ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!